Literature DB >> 24411603

Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer.

Chad Tang1, Daniel R Gomez1, Hongmei Wang2, Lawrence B Levy1, Yan Zhuang3, Ting Xu1, Quynh Nguyen1, Ritsuko Komaki1, Zhongxing Liao4.   

Abstract

PURPOSE: Radiation pneumonitis (RP) is an inflammatory response to radiation therapy (RT). We assessed the association between RP and white blood cell (WBC) count, an established metric of systemic inflammation, after RT for non-small cell lung cancer. METHODS AND MATERIALS: We retrospectively analyzed 366 patients with non-small cell lung cancer who received ≥60 Gy as definitive therapy. The primary endpoint was whether WBC count after RT (defined as 2 weeks through 3 months after RT completion) was associated with grade ≥3 or grade ≥2 RP. Median lung volume receiving ≥20 Gy (V20) was 31%, and post-RT WBC counts ranged from 1.7 to 21.2 × 10(3) WBCs/μL. Odds ratios (ORs) associating clinical variables and post-RT WBC counts with RP were calculated via logistic regression. A recursive-partitioning algorithm was used to define optimal post-RT WBC count cut points.
RESULTS: Post-RT WBC counts were significantly higher in patients with grade ≥3 RP than without (P<.05). Optimal cut points for post-RT WBC count were found to be 7.4 and 8.0 × 10(3)/μL for grade ≥3 and ≥2 RP, respectively. Univariate analysis revealed significant associations between post-RT WBC count and grade ≥3 (n=46, OR=2.6, 95% confidence interval [CI] 1.4‒4.9, P=.003) and grade ≥2 RP (n=164, OR=2.0, 95% CI 1.2‒3.4, P=.01). This association held in a stepwise multivariate regression. Of note, V20 was found to be significantly associated with grade ≥2 RP (OR=2.2, 95% CI 1.2‒3.4, P=.01) and trended toward significance for grade ≥3 RP (OR=1.9, 95% CI 1.0-3.5, P=.06).
CONCLUSIONS: Post-RT WBC counts were significantly and independently associated with RP and have potential utility as a diagnostic or predictive marker for this toxicity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24411603     DOI: 10.1016/j.ijrobp.2013.10.030

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Particle therapy in non-small cell lung cancer.

Authors:  Zhongxing Liao; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2018-04

2.  The Protective Effects and Mechanism of Doxepin on Radiation-Induced Lung Injury in Rats.

Authors:  Xinlong Wan; Xuan Shi; Mengke Li; Qing Chen; Chang Xue; Guanghui Li; Yeke Huang; Jingwen Yang; Chan Chen; Zhiyi Wang; Shumei Ma; Xiaodong Liu
Journal:  Dose Response       Date:  2022-06-07       Impact factor: 2.623

3.  Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.

Authors:  Kuan Hu; Wenyu Wu; Lin Xie; Hao Geng; Yiding Zhang; Masayuki Hanyu; Lulu Zhang; Yinghuan Liu; Kotaro Nagatsu; Hisashi Suzuki; Jialin Guo; Yundong Wu; Zigang Li; Feng Wang; Mingrong Zhang
Journal:  Acta Pharm Sin B       Date:  2021-09-22       Impact factor: 14.903

4.  Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.

Authors:  Ju Yang; Ting Xu; Daniel R Gomez; Xianglin Yuan; Quynh-Nhu Nguyen; Melenda Jeter; Yipeng Song; Stephen Hahn; Zhongxing Liao
Journal:  Oncotarget       Date:  2017-06-27

5.  Consecutive CT-guided core needle tissue biopsy of lung lesions in the same dog at different phases of radiation-induced lung injury.

Authors:  Zhongyuan Yin; Sisi Deng; Zhiwen Liang; Qiong Wang
Journal:  J Radiat Res       Date:  2016-07-15       Impact factor: 2.724

6.  WBC Associates with Readmission Following Cystectomy.

Authors:  Andrew G McIntosh; Tianyu Li; Timothy Ito; Jason Mannion; Mark Dziemianowicz; Nikhil Waingankar; Mohammed Haseebuddin; David Y T Chen; Richard E Greenberg; Rosalia Viterbo; Alexander Kutikov; Robert G Uzzo; Marc C Smaldone; Philip H Abbosh
Journal:  Bladder Cancer       Date:  2017-04-27

7.  Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation.

Authors:  Pu Zhou; Lu Chen; Dong Yan; Changlin Huang; Guangpeng Chen; Zhiyi Wang; Liangzhi Zhong; Wen Luo; Diangang Chen; Chui Chun; Shushu Zhang; Guanghui Li
Journal:  Cancer Med       Date:  2020-03-24       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.